Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Digby F Warner

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Chemmedchem|October 16, 2023
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic StabilityAndré Campaniço, Shrika G Harjivan, Elisabete Freitas, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Journal of Medicinal Chemistry|June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology TriagingRenier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Ebiomedicine|March 24, 2022
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosisDavid A Barr, Charlotte Schutz, Avuyonke Balfour, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
ACS Infectious Diseases|October 12, 2016
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for TuberculosisVinayak Singh, Stefano Donini, Angela Pacitto, et al.
The Lancet. Respiratory Medicine|March 25, 2024
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exerciseAnna K Coussens, Syed M A Zaidi, Brian W Allwood, et al.
Elife|August 2, 2023
Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasomeSophia Gessner, Zela Alexandria-Mae Martin, Michael A Reiche, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Chemmedchem|October 16, 2023
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic StabilityAndré Campaniço, Shrika G Harjivan, Elisabete Freitas, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Journal of Medicinal Chemistry|June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology TriagingRenier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Ebiomedicine|March 24, 2022
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosisDavid A Barr, Charlotte Schutz, Avuyonke Balfour, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
ACS Infectious Diseases|October 12, 2016
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for TuberculosisVinayak Singh, Stefano Donini, Angela Pacitto, et al.
The Lancet. Respiratory Medicine|March 25, 2024
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exerciseAnna K Coussens, Syed M A Zaidi, Brian W Allwood, et al.
Elife|August 2, 2023
Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasomeSophia Gessner, Zela Alexandria-Mae Martin, Michael A Reiche, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Pageof 14